Session Details
[O2]Oral Presentation 2
Sat. Sep 26, 2026 9:50 AM - 10:40 AM JST
Sat. Sep 26, 2026 12:50 AM - 1:40 AM UTC
Sat. Sep 26, 2026 12:50 AM - 1:40 AM UTC
Room 5(3F Conference Room 302A)
Chair:Koichi Hashimoto, Yosuke Yasui
[O2-01]全乳児へのニルセビマブ投与実施に向けたエビデンスの構築:三重県におけるRSウイルス感染症疫学研究 (SYMPHONIE研究)
*Shingo Mitsushima1, Hajime Kamiya1, Mizuho Nagao2, Shigeru Suga2, Kiyosu Taniguchi2 (1. Department of Public Health and Applied Epidemiology, Mie University Faculty of Medicine, 2. National Hospital Organization Mie National Hospital)
[O2-02]RSV母体免疫ワクチン定期接種前における妊婦および臍帯血のRSV-preF抗体保有状況
*Haruna Miwa1, Ritsue Nii1, Shigeru Nii2, Shota Nii2, Manami Negoro3, Anthony Simbeya3, Elijah Deku-Mwin Kuurdor4, Masayuki Fukumura5, Jyunpei Ohtsuka5, Tetsuya Nosaka6, Noriko Ogasawara7, Soh Yamamoto7, Tetsuo Nakayama8, Shigeru Suga3,9, Kiyosu Taniguchi3,9 (1. Shiroko Clinic Pediatrics, 2. Shiroko Women's Hospital, 3. Division of Clinical Research, NHO Mie National Hospital, 4. Department of Public Health, Occupational Medicine, and Applied Epidemiology, Mie University Graduate School of Medicine, 5. Biocomo, Inc., 6. Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, 7. Division of Microbiology, Department of infectious diseases, Sapporo Medical University School of medicine, 8. Omura Satoshi Memorial Institute, Kitasato University , 9. Department of Pediatrics, NHO Mie National Hospital)
[O2-03]母子免疫ワクチン接種または未接種の妊婦から出生した児およびRSウイルス感染症にて入院した生後6か月未満の児のRSウイルス Prefusion F IgG抗体価の検討
*Tomohiro Oishi1, Takashi Nakano2 (1. Department of Clinical Infectious Diseases, Kawasaki Medical School, 2. Department of Pediatrics, Kawasaki Medical School)
[O2-04]Age-dependent RSV IgG decline to define infant susceptibility window – A modelling approach
*Elijah Deku-Mwin Kuurdor1, Manami Negoro2, Amexo Xolali Jennifer3, Ken Sugata2, Prince Baffour Tonto4,5, Anthony Simbeya2,6, Junpei Ohtsuka7,8, Soh Yamamoto9, Noriko Ogasawara9, Masayuki Fukumura7,8, Tetsuya Nosaka7, Shingo Mitsushima1, Hajime Kamiya1, Kiyosu Taniguchi2 (1. Department of Public Health, Occupational Medicine and Applied Epidemiology, Mie University Graduate School of Medicine., 2. National Hospital Organization, Mie National Hospital, Tsu, Japan., 3. Department of Epidemiology and Biostatistics, University of Health and Allied Science, Ho, Ghana., 4. Rutgers Global Health Institute, Rutgers University, New Brunswick, NJ, USA., 5. Department of Medicine, Division of Allergy, Immunology, and Infectious Disease and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., 6. Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan., 7. Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan., 8. BioComo Inc., Tsu, Japan., 9. Division of Microbiology, Department of Infectious Diseases, Sapporo Medical University School of Medicine, Sapporo, Japan.)
[O2-05]妊婦2価RSV pre-Fワクチンおよびnirsevimab導入による RSV F蛋白アミノ酸配列への影響
*Hisao Okabe1,2, Koichi Hashimoto1, Sakurako Norito1, Shun Hiruta1, Jun Shirota1, Eriko Shima1, Kenshiro Tabata1, Kenta Kuwana1, Masato Hoshino1, Mamiko Nakazawa1, Masahiro Watanabe1, Fumi Mashiyama2, Hiroko Sakuma2, Mitsuaki Hosoya1, Go Hayato1 (1. Department of Pediatrics, School of Medicine, Fukushima Medical University, 2. Department of Pediatrics, Hoshi General Hospital)
